Bolt Biotherapeutics Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$5.77

+0.37 (+6.85%)

As of Feb 8, 2:28 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 7 64%

Hold 4 36%

Sell 0 0%

Price Target

Analyst Price Target +357.0% upside

Low Target $21.16

Average Target $26.37

High Target $30.50

Current Price $5.77

Current
$5.77

Target
$26.37

$21.16 $26.37 avg $30.50

Scenario Analysis

Bear Case

$21.16

266.7%

Low target

Base Case

$26.37

+357.0%

Avg target

Bull Case

$30.50

+428.6%

High target

Risk/Reward

1.6x

Balanced

Price in Context

52-Week High

$24.61

-76.6% from high

52-Week Low

$11.40

+-49.4% from low

Target vs 52W High

$26.37

+7.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%